Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2− metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial

202340 citationsJournal Articlehybrid Open Access

Authors

Nadia Harbeck · Breast Center

Peter A. Fasching · Universitätsklinikum Erlangen

Rachel Wuerstlein · Ludwig-Maximilians-Universität München

Tom Degenhardt · Breast Center

Diana Lüftner · Medizinische Hochschule Brandenburg Theodor Fontane

Ronald Kates · Deutsches Archäologisches Institut, Zentrale

Johannes Schumacher

Abstract

PreCycle is the first multicenter randomized eHealth trial demonstrating a significant benefit for MBC patients receiving oral tumor therapy when using an interactive autonomous patient empowerment application.

Topics & Keywords

Advanced Breast Cancer Therapies Cancer-related cognitive impairment studies Breast Cancer Treatment Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of Oncology

Volume 34, Issue 8, pp. 660-669

DOI: 10.1016/j.annonc.2023.05.003

Field-Weighted Citation Impact: 10.30